Sanofi begins shipment of influenza vaccine doses in US Ruchika Sharma26 July 2020 9:00 AM ISTBridgewater: Sanofi Pasteur, the vaccines global business unit of Sanofi, has shipped the first of its influenza vaccine doses to health care...
Sanofi studies potential acquisitions of US biotechnology companies including Principia Biopharma Ruchika Sharma19 July 2020 9:00 AM ISTChief Executive Officer Paul Hudson, who joined last year, is seeking to rejuvenate Sanofi by focusing on fast-growing areas where new medicines...
Sanofi, Kymera Therapeutics ink Strategic Partnership To Advance Novel Protein Degrader Therapies Ruchika Sharma12 July 2020 9:45 AM ISTKymera will receive $150 million in cash upfront and may receive more than $2 billion in potential development, regulatory and sales milestones, as...
Ensure production, adequate stock of methylprednisolone, heparin, dexamethasone: NPPA directs pharma cos Ruchika Sharma10 July 2020 4:49 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has directed State Drug Controllers (SDCs) to...
Sanofi, GSK close to USD 624 million Vaccine supply Deal: Bloomberg Ruchika Sharma6 July 2020 12:00 PM ISTUK: GlaxoSmithKline and Sanofi are close to reaching a 500 million-pound ($624 million) deal to supply the U.K. government with 60 million doses of a...
Sanofi, Regeneron arthritis drug Kevzara fails COVID-19 study Ruchika Sharma4 July 2020 10:00 AM ISTParis: Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the U.S. Phase 3 trial of Kevzara (sarilumab) 400 mg in COVID-19 patients...
Sanofi India to raise awareness about allergies Ruchika Sharma1 July 2020 11:46 AM IST"Therefore, there is a real need for a revolutionary shift in mindset towards allergies. ''AllergyFree'' is our endeavour to raise awareness so that...
Sanofi-GSK COVID-19 vaccine anticipates approval by early 2021 Ruchika Sharma24 Jun 2020 11:15 AM ISTSanofi, which is hosting virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the...
Sanofi-Regeneron Dupixent gets NMPA nod to treat atopic dermatitis Ruchika Sharma22 Jun 2020 10:30 AM ISTThe approval was based on positive data from the global LIBERTY AD clinical trial program that included nearly 3,000 patients with inadequately...
France aims for paracetamol production within three years Ruchika Sharma21 Jun 2020 9:00 AM IST"We are working with (pharmaceutical groups) Seqens, Upsa and Sanofi so that within the next three years France can produce, package and distribute...
Sanofi launches VaxLine to support child vaccination in India during COVID Ruchika Sharma18 Jun 2020 11:46 AM ISTVaxLine is a tele-counselling facility with a toll-free number 1800 123 5011 that registers a parent’s missed call and allows a VaxLine health expert...
Sanofi to present growth opportunities, development strategy for Dupixent in type 2 inflammatory diseases Ruchika Sharma14 Jun 2020 9:15 AM ISTAs announced in December 2019, Sanofi expects to deliver strong growth for Dupixent with the ambition of achieving more than €10 billion in peak sales...
